Viewing Study NCT04898504


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2025-12-31 @ 12:34 AM
Study NCT ID: NCT04898504
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-07
First Post: 2021-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.
Sponsor: Oslo University Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-23
Start Date Type: ACTUAL
Primary Completion Date: 2025-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-05
Completion Date Type: ESTIMATED
First Submit Date: 2021-05-10
First Submit QC Date: None
Study First Post Date: 2021-05-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-05
Last Update Post Date: 2024-11-07
Last Update Post Date Type: ACTUAL